Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de la Facultad de Medicina
versión impresa ISSN 0120-0011
Resumen
RINCON-ALVAREZ, Óscar Javier y NEIRA-TORRES, Liliana Isabel. Hearing loss and rheumatoid arthritis, systemic lupus erythematosus and Sjögren 's syndrome. rev.fac.med. [online]. 2018, vol.66, n.3, pp.439-446. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v66n3.60636.
Introduction:
Currently, figures on people suffering from rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or Sjögren's syndrome (SS) are not available, as well as information on auditory alterations caused by the pharmacological treatment used to control said diseases.
Objective:
To demonstrate possible hearing and vestibular disorders caused by RA, SLE and SS or their pharmacological treatment.
Materials and methods:
Clinical findings of diagnostic tools and prevention and intervention procedures for hearing disorders found in research articles published in Spanish, English, French and Portuguese in scientific databases between 2000 and 2016 were analyzed.
Results:
62 research papers were obtained (31 on RA, 5 on SLE, 12 on SS, 5 on immune-mediated hearing loss, and 9 on ototoxic drugs), a doctoral thesis on RA, a doctoral thesis on RA and LES and a clinical practice guideline for the early detection, diagnosis and treatment of RA. The most frequent types of hearing loss reported are sensorineural hearing loss, ossicular chain lesions and vestibular-cochlear disorders.
Conclusions:
The relationship between hearing lesions and RA, LES and SS was confirmed, but the development of ototoxic drugs is not clear yet.
Palabras clave : Autoimmune Diseases; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Antimalarials (MeSH).